Access cutting-edge b-cell lymphoma treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access b-cell lymphoma specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related b-cell lymphoma treatment provided free
This is a Phase I/II study designed to evaluate if experimental T cell engaging antibody targeting CD20 AZD5492 is safe, tolerable and efficacious in participants with Relapsed or Refractory B-Cell Malignancies.
Sponsor: AstraZeneca
Check if you qualify for this b-cell lymphoma clinical trial in Seattle, WA
If you're searching for b-cell lymphoma treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.